GABRIELLE AMBROSIO: Open Payments
NPI 1467183467 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,201 in 111 payments from 34 companies in 2025. Trend: 2023 $0 · 2024 $1,639 · 2025 $2,201
Food & beverage: $1,867Education: $334
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 26 | $388 |
| Janssen Biotech, Inc. | 9 | $254 |
| AstraZeneca Pharmaceuticals LP | 12 | $231 |
| Gilead Sciences, Inc. | 4 | $220 |
| E.R. Squibb & Sons, L.L.C. | 15 | $215 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Celgene Corporation | 4 | $74 |
| BeOne Medicines USA, Inc. | 3 | $63 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $50 |
| Tempus AI, Inc | 1 | $44 |
Products named: Enhertu, Trodelvy, RYBREVANT, CALQUENCE, OPDIVO, OPDUALAG, KEYTRUDA, REBLOZYL.
Industry payments across NJ — which companies pay providers there.
